CoChat

Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study

Open access
van Eijk, Lucas T, Kroot, Joyce JC, Tromp, Mirjam, van der Hoeven, Johannes G, Swinkels, Dorine W, Pickkers, Peter · 2011 · Critical Care

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Anemia is a frequently encountered problem during inflammation. Hepcidin is an interleukin-6 (IL-6)-induced key modulator of inflammation-associated anemia. Human sepsis is a prototypical inflammatory syndrome, often complicated by the development of anemia. However, the association between inflammation, hepcidin release and anemia has not been demonstrated in this group of patients. Therefore, we explored the association between hepcidin and sepsis-associated anemia. METHODS: 92 consecutive patients were enrolled after presentation on the emergency ward of a university hospital with sepsis, indicated by the presence of a proven or suspected infection and ≥ 2 extended systemic inflammatory response syndrome (SIRS) criteria. Blood was drawn at day 1, 2 and 3 after admission for the measurement of IL-6 and hepcidin-25. IL-6 levels were correlated with hepcidin concentrations. Hemoglobin levels and data of blood transfusions during 14 days after hospitalisation were retrieved and the rate of hemoglobin decrease was correlated to hepcidin levels. RESULTS: 53 men and 39 women with a mean age of 53.3 ± 1.8 yrs were included. Hepcidin levels were highest at admission (median[IQR]): 17.9[10.1 to 28.4]nmol/l and decreased to normal levels in most patients within 3 days (9.5[3.4 to 17.9]nmol/l). Hepcidin levels increased with the number of extended SIRS criteria (P = 0.0005). Highest IL-6 levels were measured at admission (125.0[46.3 to 330.0]pg/ml) and log-transformed IL-6 levels significantly correlated with hepcidin levels at admission (r = 0.28, P = 0.015), day 2 (r = 0.51, P < 0.0001) and day 3 (r = 0.46, P < 0.0001). Twelve patients received one or more blood transfusions during the first 2 weeks of admission, not related to active bleeding. These patients had borderline significant higher hepcidin level at admission compared to non-transfused patients (26.9[17.2 to 53.9] vs 17.9[9.9 to 28.8]nmol/l, P = 0.052). IL-6 concentrations did not differ between both groups. Correlation analyses showed significant associations between hepcidin levels on day 2 and 3 and the rate of decrease in hemoglobin (Spearman's r ranging from -0.32, P = 0.03 to -0.37, P = 0.016, respectively). CONCLUSIONS: These data suggest that hepcidin-25 may be an important modulator of anemia in septic patients with systemic inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/cc9408

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Association between IL-6, hepcidin and hemoglobin decrease. (a) Humoral relation between inflammation and hepcidin levels: Pearson's correlation between the natural logarithm (Ln) of IL-6 and hepcidin-25 on day 2 (black diamonds, uninterrupted line), and day 3 (grey dots, dashed line. The correlation on day 1 (r = 0.28, P = 0.015), was omitted for reasons of clarity. The median reference level of serum hepcidin-25 is 4.2 nM, range 0.5 to 13.9 nM [15]. (b) Clinical relation between inflammation and hepcidin levels: hepcidin-25 levels according to the number of extended systemic inflammatory response syndrome (SIRS) criteria at presentation at the emergency ward [13]. Differences were tested with Kruskal-Wallis. (c) Spearman's correlation between rate of hemoglobin (Hb) decrease and hepcidin-25 concentration on day 2 (black dots, uninterrupted line) and day 3 (open triangles, dashed line). The rate of decrease was only calculated in patients that did not receive a blood transfusion and of whom Hb was measured at least once between day 7 and 14 of hospital admission (n = 44). (d) Relation between hepcidin-25 levels at admission and the number of blood transfusions received during 14 days of follow up. Boxes represent median and interquartile range, whiskers represent 5th and 95th percentile. Difference between transfused and non-transfused patients was tested with a Mann Whitney test.
Figure 1 Association between IL-6, hepcidin and hemoglobin decrease. (a) Humoral relation between inflammation and hepcidin levels: Pearson's correlation between the natural logarithm (Ln) of IL-6 and hepcidin-25 on day 2 (black diamonds, uninterrupted line), and day 3 (grey dots, dashed line. The correlation on day 1 (r = 0.28, P = 0.015), was omitted for reasons of clarity. The median reference level of serum hepcidin-25 is 4.2 nM, range 0.5 to 13.9 nM [15]. (b) Clinical relation between inflammation and hepcidin levels: hepcidin-25 levels according to the number of extended systemic inflammatory response syndrome (SIRS) criteria at presentation at the emergency ward [13]. Differences were tested with Kruskal-Wallis. (c) Spearman's correlation between rate of hemoglobin (Hb) decrease and hepcidin-25 concentration on day 2 (black dots, uninterrupted line) and day 3 (open triangles, dashed line). The rate of decrease was only calculated in patients that did not receive a blood transfusion and of whom Hb was measured at least once between day 7 and 14 of hospital admission (n = 44). (d) Relation between hepcidin-25 levels at admission and the number of blood transfusions received during 14 days of follow up. Boxes represent median and interquartile range, whiskers represent 5th and 95th percentile. Difference between transfused and non-transfused patients was tested with a Mann Whitney test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

Metadata

Authors
van Eijk, L. T., Kroot, J. J., Tromp, M., van der Hoeven, J. G., Swinkels, D. W., & Pickkers, P.
Affiliations
  • Radboud University Medical Center (NL)
  • Radboud University Nijmegen (NL)
Corresponding author
Pickkers, Peter
Venue
Critical Care
Published
2011-01-10
Volume
15
Issue
1
Pages
R9-R9
ISSN
1364-8535 (ISSN-L)
OpenAlex
W2162747635
Cited by
48
References
22
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 7 · 2018: 4 · 2017: 1 · 2016: 4 · 2015: 8 · 2014: 3 · 2013: 1 · 2012: 4
FWCI
1.97
Type
journal article
Language
en
Open access
Licence
Locations
  • Critical Care (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
ZonMw
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
Keywords
hepcidin-25, interleukin-6, inflammation, systemic inflammatory response syndrome, blood transfusion, hemoglobin decrease, iron metabolism, sepsis
MeSH terms
Anemia, Blood Transfusion, Female, Hemoglobins, Humans, Inflammation, Male, Middle Aged, Prospective Studies, Interleukin-6, Sepsis, Antimicrobial Cationic Peptides, Hepcidins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.